6-oxa and thiabicyclo [3.1.0.] compounds

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546269, 546274, 549546, C07D30334, C07D33102

Patent

active

050434560

ABSTRACT:
There are provided compounds of the formula: ##STR1## wherein R.sub.1 is a hydrogen or C.sub.1 -C.sub.5 alkyl; R.sub.2 is an C.sub.1 -C.sub.10 alkyl, aryl, aralkyl, or pyridyl, where the aryl, aralkyl, or pyridyl are unsubstituted or are substituted by C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, nitro, hydroxy, carboxy, amino, C.sub.1 -C.sub.5 alkylamino, C.sub.1 -C.sub.5 dialkyamino whose two alkyl groups may be different from each other, C.sub.2 -C.sub.3 alkanoylamino, or halogen and X is an C.sub.1 -C.sub.7 alkylene, C.sub.2 -C.sub.7 alkenylene, --CH(F)CH.dbd.CH(CH.sub.2).sub.3 --, --(CH.sub.2).sub.3 --S--(CH.sub.2).sub.2 --, --(CH.sub.2).sub.2 --S--(CH.sub.2).sub.3 --, --C.sub.6 H.sub.4 -O--CH.sub.2 -- or --CH.sub.2 CH.dbd.CH--m--C.sub.6 H.sub.4 --, or their pharmaceutically accepatble salts. The compounds are useful as antithrombotic, anti-vasconstricting and anti-bronchoconstricting drugs.

REFERENCES:
patent: 4654357 (1987-03-01), Nakane
patent: 4861913 (1989-08-01), Narisada et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

6-oxa and thiabicyclo [3.1.0.] compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-oxa and thiabicyclo [3.1.0.] compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-oxa and thiabicyclo [3.1.0.] compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1415277

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.